Lymphomatosis cerebri: a treatable cause of rapidly progressive dementia.
Department of Neuroinflammation, The National Hospital for Neurology and Neurosurgery, London, UK.
Amit
A
Samani
Brain Repair and Rehabilitation Unit, UCL Institute of Neurology, London, UK.
Indran
I
Davagnanam
Department of Neurology, The Wellington Hospital, London, UK.
Oliver Charles
OC
Cockerell
Department of Cellular Pathology, University College London Hospital, London, UK.
Alan
A
Ramsay
Department of Neuroinflammation, The National Hospital for Neurology and Neurosurgery, London, UK Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK University of Edinburgh, Edinburgh, UK.
Rickie
R
Patani
Department of Neuroinflammation, The National Hospital for Neurology and Neurosurgery, London, UK.
Jeremy
J
Chataway
D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000627:therapeutic use; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D059906:Neuroimaging; D049268:Positron-Emission Tomography; D011878:Radiotherapy; D000069283:Rituximab
D058846:Antibodies, Monoclonal, Murine-Derived; D003561:Cytarabine; D000069283:Rituximab; D008727:Methotrexate
Clinical Neurology; Lymphoma; Neurooncology